Home:
PCU 4 2002: CME Audio Series and Activity
Prostate Cancer Update: A CME Audio Series and Activity
Statement of Need/Target Audience
Prostate cancer is one of the most rapidly evolving fields
in urology. Published results from clinical trials lead to the emergence
of new surgical and radiation therapy techniques and therapeutic
agents, along with changes in the indications for existing treatments.
In order to offer optimal patient care — including the option
of clinical trial participation — the practicing urologist
must be well-informed of these advances.
To bridge the gap between research and patient care, Prostate
Cancer Update utilizes one-on-one discussions with leading urologic
oncology investigators. By providing access to the latest research
developments and expert perspectives, this CME program assists physicians
in the formulation of up-to-date clinical management strategies.
Issue 4, 2002 of Prostate Cancer Update consists of discussions
with four research leaders on a variety of important issues, including
antiandrogen withdrawal response, timing and choice of hormonal
therapy, extent of pelvic lymphadenectomy, appropriate biopsy algorithms,
and effects of androgen deprivation on bone.
Learning Objectives
Upon completion of this activity, participants should be
able to:
- Discuss how to use antiandrogen withdrawal as an intervention
for prostate cancer patients progressing on combined androgen
blockade.
- Explain the rationale for monitoring patients with elevated
PSAs and two negative biopsies, rather than obtaining further
biopsies.
- Compare the treatment trends in CaPSURE to one’s own
management of prostate cancer patients.
- Describe how to counsel prostate cancer patients about the
timing and choice of hormonal therapy.
- Explain the staging and therapeutic implications of extended
pelvic lymphadenectomy in patients undergoing radical prostatectomy.
- Identify the effects of androgen deprivation therapy on bone
and possible interventions in prostate cancer patients.
- Review the relationship between obesity and race in predicting
adverse pathologic variables in patients undergoing radical prostatectomy.
Accreditation Statement
This activity has been planned and implemented in accordance with
the Essential Areas and Policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint sponsorship
of the Postgraduate Institute for Medicine and NL Communications,
Inc. The Postgraduate Institute for Medicine is accredited by the
ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Postgraduate Institute for Medicine designates this educational
activity for a maximum of 3 hours in category 1 credit toward the
AMA Physician's Recognition Award. Each physician should claim only
credits that he/she actually spent in the activity.
Faculty Disclosure Statements
The Postgraduate Institute for Medicine has a conflict of interest
policy that requires course faculty to disclose any real or apparent
commercial financial affiliations related to the content of their
presentations/materials. It is not assumed that these financial
interests or affiliations will have an adverse impact on faculty
presentations; they are simply noted in this supplement to fully
inform participants.
|
